LEXICON PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.71 EUR | +3.23% |
|
-.--% | -14.52% |
| 07-08 | Lexicon Pharmaceuticals Names Mike Exton CEO, Jeff Wade Operating Chief | MT |
| 07-08 | Lexicon Pharmaceuticals, Inc. Announces Appointment of Mike Exton, Ph.D. as Chief Executive Officer | CI |
Chart calendar Lexicon Pharmaceuticals, Inc.
7142cc10b80316da4810acbd6a.mUXAuJR-KEueU0SA45ChNVKhlyGea5a-k_ejRBjVwFY.8wyL2qc3SzKmEAXzqenKWx2Y73n3Wu_H-ajyMkC2qWbjCJLioDF3EvQLDQ~4b260d7493b21adca3048f40fb67019a
Upcoming events on Lexicon Pharmaceuticals, Inc.
Past events on Lexicon Pharmaceuticals, Inc.
| 05/06/2024 20:00 | Jefferies Global Healthcare Conference |
| 14/05/2024 16:00 | BofA Securities Health Care Conference |
| 10/05/2024 14:00 | Annual General Meeting |
| 02/05/2024 22:00 | Q1 2024 Earnings Call |
| 02/05/2024 21:05 | Q1 2024 Earnings Release |
| 22/04/2024 14:00 | Investor Day |
| 15/04/2024 | Piper Sandler Spring Biopharma Symposium |
| 10/04/2024 18:30 | Needham Healthcare Conference |
| 09/04/2024 | Piper Sandler Virtual Cardiovascular Day |
| 08/04/2024 17:25 | American College of Cardiology Scientific Meeting - Sotagliflozin Reduces Stroke |
| 08/04/2024 17:15 | American College of Cardiology Scientific Meeting - Rahul Aggarwal |
| 07/04/2024 | Needham Healthcare Conference |
| 07/04/2024 18:15 | American College of Cardiology Scientific Meeting - Preston Mason |
| 07/04/2024 18:15 | American College of Cardiology Scientific Meeting - Sotagliflozin, a Dual SGLT 1 and 2 Inhibitor |
| 07/04/2024 16:30 | American College of Cardiology Scientific Meeting - Livia Stanger |
| 07/04/2024 16:30 | American College of Cardiology Scientific Meeting - Sotagliflozin, a First-in-Class SGLT1/2 Inhibito |
| 07/04/2024 15:00 | American College of Cardiology Scientific Meeting - Temporal Shift in Heart Failure Medications |
| 07/04/2024 14:15 | American College of Cardiology Scientific Meeting - Mario Enrico Canonico |
| 12/03/2024 19:40 | Leerink Partners Global Biopharma Conference |
| 11/03/2024 11:15 | Q4 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 322 323 -0.44% | 24,0 77,0 -68.86% | 0,30 0,29 3% | 0,14 0,14 -1.19% | 1,20 1,74 -30.94% | 28,0 |
|
EBITDA Million USD | Released Forecast Spread | 174 112 55.18% | -44,9 -134 66.46% | -86,8 -88,0 1.39% | -100 -94,2 -6.54% | -171 -178 3.7% | -175 |
|
EBIT Million USD | Released Forecast Spread | 141 110 28.06% | -47,8 -71,9 33.54% | -87,1 -88,8 1.88% | -101 -95,0 -6.06% | -172 -178 3.33% | -185 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 124 86,6 43.37% | -58,6 -137 57.12% | -87,8 -89,2 1.61% | -102 -96,3 -5.91% | -176 -181 2.9% | -191 |
|
Net income Million USD | Released Forecast Spread | 130 96,1 35.36% | -58,6 -123 52.52% | -87,8 -89,2 1.61% | -102 -96,3 -5.91% | -176 -181 2.9% | -194 |
|
EPS USD | Released Forecast Spread | 1,16 0,84 37.65% | -0,53 -1,10 51.62% | -0,60 -0,61 0.91% | -0,62 -0,56 -10.11% | -0,79 -0,80 0.78% | -0,75 |
| Announcement Date | 12/03/20 | 10/03/21 | 28/02/22 | 02/03/23 | 11/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,04 0,05 -26% | 0,04 0,10 -65% | 0,04 0,05 -22% | 0,03 0,05 -44% | 0,02 0,03 -27.99% | 0,32 0,13 137.76% | 0,16 2,06 -92.14% | 0,70 1,24 -43.47% | 1,13 1,40 -19.33% | 3,44 | 8,98 | 14,4 | 15,4 | 17,5 |
|
EBITDA Million USD | Released Forecast Spread | -23,3 -24,0 3.04% | -46,6 -53,2 12.38% | -45,2 -50,7 10.92% | -45,1 | -43,3 | -41,6 | ||||||||
|
EBIT Million USD | Released Forecast Spread | -23,4 -23,7 1.35% | -24,0 -23,9 -0.45% | -23,1 -23,0 -0.57% | -30,3 -24,7 -22.42% | -31,1 -31,3 0.48% | -44,2 -34,9 -26.83% | -49,6 -47,8 -3.9% | -46,7 -52,6 11.16% | -45,3 -51,0 11.02% | -49,1 | -48,5 | -50,7 | -50,1 | -52,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,5 -23,7 0.95% | -24,6 -23,9 -2.87% | -23,4 -23,0 -1.84% | -30,5 -24,7 -23.29% | -31,9 -31,6 -1.19% | -44,9 -35,2 -27.52% | -50,5 -48,0 -5.33% | -48,2 -53,5 9.74% | -48,4 -51,0 5.13% | -48,6 | -46,6 | -47,8 | -50,1 | -52,3 |
|
Net income Million USD | Released Forecast Spread | -23,5 -23,7 0.95% | -24,6 -23,9 -2.87% | -23,4 -23,0 -1.84% | -30,5 -24,7 -23.29% | -31,9 -31,6 -1.19% | -44,9 -35,2 -27.52% | -50,5 -48,0 -5.33% | -48,2 -53,5 9.74% | -48,4 -50,8 4.66% | -49,3 | -47,6 | -48,4 | -50,1 | -52,3 |
|
EPS USD | Released Forecast Spread | -0,16 -0,17 3.43% | -0,16 -0,16 0.69% | -0,13 -0,14 7.2% | -0,16 -0,13 -19.53% | -0,17 -0,18 5.21% | -0,22 -0,17 -25.97% | -0,21 -0,21 2.17% | -0,20 -0,22 7.91% | -0,20 -0,20 -1.27% | -0,19 | -0,18 | -0,18 | -0,17 | -0,17 |
| Announcement Date | 05/05/22 | 02/08/22 | 09/11/22 | 02/03/23 | 02/05/23 | 03/08/23 | 08/11/23 | 11/03/24 | 02/05/24 | - | - | - | - | - |
More events
Past sector events for Lexicon Pharmaceuticals, Inc.
| 11/07/2024 21:00 | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
| 04/07/2024 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
| 05/06/2024 08:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 15/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 13:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LXRX Stock
- LX31 Stock
- Calendar Lexicon Pharmaceuticals, Inc.
